Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease.
Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, Kuwana M; the Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators.
Gono T, et al. Among authors: kuwana m.
Arthritis Rheumatol. 2021 Apr;73(4):677-686. doi: 10.1002/art.41566. Epub 2021 Feb 22.
Arthritis Rheumatol. 2021.
PMID: 33118321